Overview

A Study to Evaluate the Efficacy and Safety of ANB019 in the Treatment of Subjects With Ichthyosis

Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
Efficacy and Safety of ANB019 in Subjects with Ichthyosis
Phase:
Phase 2
Details
Lead Sponsor:
AnaptysBio, Inc.